Friday, July 19, 2019

Pharma News

Health Europa brings you the latest Pharma News the field of European Healthcare & Social Care Policy.

Oesophageal cancer can be prevented by taking two medications

Oesophageal cancer can be prevented by taking two medications

Taking a combination of an anti-reflux medication and a low dose of aspirin can prevent oesophageal cancer in people at higher risk, according to...
Can antidepressants increase the risk of weight gain?

Can antidepressants increase the risk of weight gain?

A new study published in The BMJ today has found that long term use of antidepressants is linked to the increase in risk of...
European Commission approves single pill for HIV-1 treatment

European Commission approves single pill for HIV-1 treatment

The Janssen Pharmaceutical Companies of Johnson & Johnson have today announced that the European Commission has approved JULUCA® (dolutegravir/rilpivirine), a once daily single pill...
EMA recalls multiple sclerosis drug from hospitals and pharmacies

EMA recalls multiple sclerosis drug from hospitals and pharmacies

The European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has confirmed that the multiple sclerosis drug Zinbryta has been recalled from hospitals and...
Six months of Herceptin good for women with HER2-positive breast cancer

Six months of Herceptin good for women with HER2-positive breast cancer

Taking Herceptin for six months could be just as effective as taking it for 12 months in preventing relapse and death, as well as...
NICE recommends Biogen’s Avonex for multiple sclerosis

NICE recommends Biogen’s Avonex for multiple sclerosis

The National Institute for Heath and Care Excellence (NICE) has announced its recommendation of Biogen’s Avonex® (interferon beta-1a), which is used as an option...
New oral drug can protect cancer patients from venous thromboembolism

New oral drug can protect cancer patients from venous thromboembolism

Taking one tablet a day could be the key to helping treat cancer patients and protect them from venous thromboembolism (VTE), according to research...
NHS funding could hinder patient’s access to drugs warns King’s Fund

NHS funding could hinder patient’s access to drugs warns King’s Fund

A new report from The King’s Fund has revealed that NHS funding levels are not keeping pace with growth in NHS spending on medicines,...
ECDC highlights future threat of drug-resistant gonorrhoea

ECDC highlights future threat of drug-resistant gonorrhoea

Following three cases of antibiotic-resistant gonorrhoea in Europe and Australia, there is concern that the growing threat of drug resistance could lead to untreatable...
Three new medicines recommended for approval

Three new medicines recommended for approval

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) have recommended three new medicines for approval that will treat numerous...
Common heartburn drug linked to pneumonia in older adults

Common heartburn drug linked to pneumonia in older adults

Pneumonia development in older adults has been found to have a link with the consumption of a group of certain medicines commonly used to...
Existing antiviral drugs have new uses against multiple viruses

Existing antiviral drugs have new uses against multiple viruses

A test of 55 antiviral drugs by the Norwegian University of Science and Technology (NTNU), has found seven compounds that show new effects against...

Health Special Reports

Health eBooks

Health Partners

Pin It on Pinterest